Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi Therapeutics (MGX) Change in Accured Expenses (2023 - 2025)

Metagenomi (MGX) has disclosed Change in Accured Expenses for 3 consecutive years, with -$3.2 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses fell 902.83% to -$3.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.6 million through Dec 2025, down 83.87% year-over-year, with the annual reading at -$1.6 million for FY2025, 83.87% down from the prior year.
  • Change in Accured Expenses for Q4 2025 was -$3.2 million at Metagenomi, down from $4.0 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $4.0 million in Q3 2025, with the low at -$3.2 million in Q4 2025.
  • Average Change in Accured Expenses over 3 years is -$75500.0, with a median of -$73000.0 recorded in 2024.
  • Peak annual rise in Change in Accured Expenses hit 539.67% in 2025, while the deepest fall reached 902.83% in 2025.
  • Over 3 years, Change in Accured Expenses stood at $902000.0 in 2023, then tumbled by 135.25% to -$318000.0 in 2024, then crashed by 902.83% to -$3.2 million in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at -$3.2 million, $4.0 million, and $172000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.